PIRS - Pieris Pharmaceuticals EPS beats by $0.18 beats on revenue November, 11 2019 07:06 AM Pieris Pharmaceuticals Inc. Pieris Pharmaceuticals (NASDAQ:PIRS): Q3 GAAP EPS of -$0.05 beats by $0.18.More news on: Pieris Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...